PW MEDTECH GROUP DL-0001 Total Assets
PW MEDTECH GROUP DL-0001 total assets. Based on the latest financial reports, PW MEDTECH GROUP DL-0001 (PWE) holds total assets worth €5.24 Billion EUR (≈ $6.12 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see PWE company net worth for the company's overall valuation and market capitalisation.
Total Assets of PW MEDTECH GROUP DL-0001 (2021–2025)
Total assets of PW MEDTECH GROUP DL-0001 from 2021 to 2025. This chart illustrates how PW MEDTECH GROUP DL-0001's total assets have evolved over time, based on quarterly financial data. See PW MEDTECH GROUP DL-0001 share price for real-time trading data and today's change.
PW MEDTECH GROUP DL-0001 - Asset Composition Analysis
PW MEDTECH GROUP DL-0001 Total Assets Breakdown (December 2025)
PW MEDTECH GROUP DL-0001 total assets breakdown as of December 2025. PW MEDTECH GROUP DL-0001's total assets of €5.24 Billion consist of 45.1% current assets and 54.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 34.4% |
| Accounts Receivable | €67.39 Million | 1.3% |
| Inventory | €145.20 Million | 2.8% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.02 Billion | 19.5% |
| Goodwill | €564.09 Million | 10.8% |
Asset Composition Trend (2021–2025)
This chart illustrates how PW MEDTECH GROUP DL-0001's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore PW MEDTECH GROUP DL-0001 (PWE) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PW MEDTECH GROUP DL-0001's current assets represent 45.1% of total assets in 2025, a decrease from 66.2% in 2021.
- Cash Position: Cash and equivalents constituted 34.4% of total assets in 2025, down from 58.4% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 4.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 19.5% of total assets.
PW MEDTECH GROUP DL-0001 Competitors by Total Assets
Key competitors of PW MEDTECH GROUP DL-0001 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.76 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.26 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK
|
Indonesia | Rp980.33 Billion |
|
Medeon Biodesign
TWO:6499
|
Taiwan | NT$1.55 Billion |
|
ZENTEK LTD.
F:ZAY0
|
Germany | €17.38 Million |
PW MEDTECH GROUP DL-0001 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 10.89 | 11.80 | 9.68 |
| Quick Ratio | 10.22 | 11.12 | 9.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €2.14 Billion | €1.92 Billion | €1.93 Billion |
PW MEDTECH GROUP DL-0001 - Advanced Valuation Insights
This section examines the relationship between PW MEDTECH GROUP DL-0001's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.33 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 1.4% |
| Total Assets | €5.24 Billion |
| Market Capitalization | $142.76 Million USD |
Valuation Analysis
Below Book Valuation: The market values PW MEDTECH GROUP DL-0001's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: PW MEDTECH GROUP DL-0001's assets grew by 1.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for PW MEDTECH GROUP DL-0001 (2021–2025)
The table below shows the annual total assets of PW MEDTECH GROUP DL-0001 from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €5.24 Billion ≈ $6.12 Billion |
+1.44% |
| 2024-12-31 | €5.16 Billion ≈ $6.03 Billion |
+0.17% |
| 2023-12-31 | €5.15 Billion ≈ $6.02 Billion |
+3.27% |
| 2022-12-31 | €4.99 Billion ≈ $5.83 Billion |
+27.43% |
| 2021-12-31 | €3.92 Billion ≈ $4.58 Billion |
-- |
About PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infus… Read more